A pitch reducer (5) is arranged in the hub.

The tower and the base are made of a high-strength low-alloy material, and the hub, the bearing seat, the pitch reducer shell and the yaw reducer shell are made of a ductile cast iron material.

A pitch reducer (5) is arranged in the hub.

A reductant tank stores a reductant.

A reductant pump pumps the reductant from the reductant tank to the injector.

Reduction gas may thus be also supplied to the radial inner area of the reduction shaft, so that the introduction of dust by the reduction gas is not limited to the outer area of the bulk material in the reduction shaft.

A solid pharmaceutical preparation which contains an insulin resistance reducer and an active ingredient (which is not an insulin resistance reducer).

A reduced reductant flow rate may be determined for a reductant dosing command value based, at least in part, on the determined flow rate offset when reductant dosing command is non-zero.

A reductant tank is configured to store a reductant.

The reductant doser is responsive to a reductant doser command.

The improved polydextrose of this invention has substantially no reducing glucose groups.

The reducing agent feed pump feeds the reducing agent from the reducing agent tank to the reducing agent injection device.

The reducing agent tank stores the reducing agent.

The pharmaceutical composition does not substantially contain, as the pharmaceutically acceptable carrier, a reducing sugar and/or a carrier containing a reducing sugar as an ingredient.

A sensor is in fluid communication with the reductant and outputs a reductant quality signal based on the reductant.